Skip to main content
Veterinary Medicines

Cortizeme külsőleges szuszpenzió

Authorised
  • Prednisolone
  • NEOMYCIN SULFATE

Product identification

Medicine name:
Cortizeme külsőleges szuszpenzió
Active substance:
  • Prednisolone
  • NEOMYCIN SULFATE
Target species:
  • Dog
  • Cat
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Prednisolone
    0.01
    gram(s)
    /
    100.00
    millilitre(s)
  • NEOMYCIN SULFATE
    5000.00
    international unit(s)
    /
    1.00
    litre(s)
Pharmaceutical form:
  • Cutaneous suspension
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD07CA03
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Available in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 20/11/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 20/11/2023

Labelling

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 20/11/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."